Oncotarget On Taget for Cancer Research

For a number of years, a scientific research journal has been changing and reshaping the fields of medical and oncology research. Started in only 2010 by two cancer researchers and medical professionals, Oncotarget blossomed into one of the most widely used and accepted journals in medical history.

Although focusing on oncology (cancer research and treatment), Oncotarget also publishes articles on other important medical research, making it a far more dynamic and useful tool for researchers and doctors than it would otherwise be. The journal is published by Impact, with two editors-in-chief, Mikhail Blagosklonny and Andrei V. Gudkov. Dr. Blagosklonny received his medical degree at the University of St. Petersburg, Russia. He also received his research degree at the same institution. Andrei V. Gudkov received his medical degree at Roswell Park Cancer Institute. Follow Oncotarget on Twitter.

Although publishing articles on other forms of medical research, Oncotarget’s main focus is on the research and treatment of cancer. It is an open-access journal, so to speak, and the articles are fist assessed by the two editors-in-chief.

As late as July of 2017, Oncotarget proved useful to researchers and treatment centers in the field of cancer, with an article on thyroid cancer. A group of Chinese doctors shared a treatment for thyroid cancer in the journal, and every researcher and cancer doctor in the world had instant access to the material. This proved effective and was well received as doctors elsewhere were able to adapt and use the techniques described in the journal. Listen to Oncotarget podcast on Player.FM.

Oncotarget is one of the top four medical journals in the world, accessed by thousand of researchers and doctors daily. It is abstracted and indexed in a number of medical indices.

Know more: https://www.researchgate.net/journal/1949-2553_Oncotarget